Due to the lipophilicity of CPF, the nervous system is a primary target for CPF; hence, it can facilely pass the blood–brain barrier and dismantle its stability, resulting in disruption of neuronal transmission and development of neurological disorders [5,6]. Here, NR5A2 is linked to nervous system disorder.